{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T22:29:01Z","timestamp":1748816941091},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1097\/aco.0000000000000464","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T14:50:14Z","timestamp":1489848614000},"page":"326-334","source":"Crossref","is-referenced-by-count":3,"title":["Clinical \u2018pearls\u2019 of maternal critical care Part 2"],"prefix":"10.1097","volume":"30","author":[{"given":"Vinod","family":"Patil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamunu","family":"Ratnayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina","family":"Fastovets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1471-0528.2005.00678.x","article-title":"Fecundity and pregnancy outcome in a cohort with sickle cell-haemoglobin C disease followed from birth","volume":"112","author":"Serjeant","year":"2005","journal-title":"BJOG"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3109\/14767058.2014.928855","article-title":"Pregnancy in patients with sickle cell disease: maternal and perinatal outcomes","volume":"28","author":"Costa","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bpobgyn.2011.10.001","article-title":"The obstetric management of sickle cell disease","volume":"26","author":"Howard","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2141.2006.06103.x","article-title":"Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease","volume":"134","author":"Duits","year":"2006","journal-title":"Br J Haematol"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejogrb.2010.05.022","article-title":"Pregnancy in sickle cell disease: maternal and fetal outcomes in a population receiving prophylactic partial exchange transfusions","volume":"152","author":"Ngo","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2014-11-607317","article-title":"Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis","volume":"125","author":"Oteng-Ntim","year":"2015","journal-title":"Blood"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1471-0528.1995.tb10900.x","article-title":"Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome","volume":"102","author":"Howard","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/blood-2015-04-638288","article-title":"Pregnancy in sickle cell disease is at very high risk","volume":"125","author":"de Montalembert","year":"2015","journal-title":"Blood"},{"key":"R12-10-20210129","first-page":"CD010378","article-title":"Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy","volume":"12","author":"Okusanya","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijgo.2006.02.007","article-title":"Sickle cell disease and pregnancy in Bahrain","volume":"93","author":"Rajab","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00006250-198602000-00012","article-title":"Pregnancy in sickle cell disease","volume":"67","author":"Powars","year":"1986","journal-title":"Obstet Gynecol"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1365-2141.2003.04193.x","article-title":"Guidelines for the management of acute painful crisis in sickle cell disease","volume":"120","author":"Rees","year":"2003","journal-title":"Br J Haematol"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/ACO.0000000000000339","article-title":"Clinical pearls of maternal critical care: Part I","volume":"29","author":"Vinod","year":"2016","journal-title":"Curr Opin Anaesthesiol"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"e2014018","DOI":"10.4084\/mjhid.2014.018","article-title":"Procalcitonin as a biomarker of bacterial infection in sickle cell vaso-occlusive crisis","volume":"6","author":"Patel","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"e2011028","DOI":"10.4084\/mjhid.2011.028","article-title":"The role of infection in the pathogenesis of vaso-occlusive crisis in patients with sickle cell disease","volume":"3","author":"Ahmed","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0029-7844(95)00367-3","article-title":"Pregnancy in sickle cell disease: experience of the Cooperative Study of Sickle Cell Disease","volume":"87","author":"Smith","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/01.AOG.0000127433.23611.54","article-title":"Outcome of pregnancy in homozygous sickle cell disease","volume":"103","author":"Serjeant","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Clin Apher"},{"key":"R23-10-20210129","first-page":"805","article-title":"Impact of sickle hemoglobinopathies on pregnancy-related venous thromboembolism","volume":"31","author":"Porter","year":"2014","journal-title":"Am J Perinatol"},{"key":"R24-10-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bpobgyn.2011.10.001","article-title":"The obstetric management of sickle cell disease","volume":"26","author":"Howard","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R27-10-20210129","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"key":"R28-10-20210129","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/00000542-198905000-00032","article-title":"Use of the cell saver in patients with sickle cell trait","volume":"70","author":"Brajtbord","year":"1989","journal-title":"Anesthesiology"},{"key":"R29-10-20210129","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijoa.2008.06.010","article-title":"Use of cell salvage in patients with sickle cell trait","volume":"18","author":"Okunuga","year":"2009","journal-title":"Int J Obst Anesth"},{"key":"R30-10-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00000542-199007000-00025","article-title":"Intraoperative autotransfusion for a patient with homozygous sickle cell disease","volume":"73","author":"Cook","year":"1990","journal-title":"Anesthesiology"},{"key":"R31-10-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3949\/ccjm.61.2.137","article-title":"Autologous blood transfusion and intraoperative cell salvage in a patient with homozygous sickle cell disease","volume":"61","author":"Fox","year":"1994","journal-title":"Cleve Clin J Med"},{"key":"R32-10-20210129","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00277-010-0936-y","article-title":"Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease","volume":"89","author":"Niall","year":"2010","journal-title":"Ann Hematol"},{"key":"R33-10-20210129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCULATIONAHA.109.882464","article-title":"Open heart surgery in patients with sickle cell hemoglobinopathy","volume":"121","author":"Yousafzai","year":"2010","journal-title":"Circulation"},{"key":"R34-10-20210129","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"R35-10-20210129","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R36-10-20210129","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R37-10-20210129","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","article-title":"Pathophysiology and treatment of pulmonary hypertension in sickle cell disease","volume":"127","author":"Gordeuk","year":"2016","journal-title":"Blood"},{"key":"R38-10-20210129","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bjhh.2014.05.007","article-title":"Clinical complications in pregnant women with sickle cell disease: prospective study of factors predicting maternal death or near miss","volume":"36","author":"Resende Cardoso","year":"2014","journal-title":"Rev Bras hematol hemoter"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000000464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:47:46Z","timestamp":1620946066000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001503-201706000-00010"}},"subtitle":["sickle-cell disease in pregnancy"],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000000464","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}